NEW THERAPY OF COWS’ POSTNATAL ENDOMETRITIS
Among postnatal pathologies in cows, a special place is occupied by acute postnatal endometritis that can cover up to 40–50 % of new–calving cows and is a primary cause of disorders in animals’ reproduction. To treat the disease, Closed Joint Stock «Rosvetfarm» (Krasnoobsk town, Novosibirsk region) developed a unique complex antimicrobial preparation Emexid, which active substances are enrofloxacin and metronidazolum. The medicinal preparation is low-toxic for lab animals and is referred to the substances of danger class III in agreement with GOST (State Standard) 12.1.00–76, it does not produce any allergenic and sensibilizing action on cutaneous covering and mucous membranes, it is highly active for reference strains and field isolates of mocroflora detected in acute postnatal endometritis in cows. Emexid has high therapeutic effect – 95 % with the therapy duration making up 5.21 ± 0.79 days. Its economic efficiency is 50.09 rubles for 1 ruble of costs. The preparation effect is favorable for the cow organism affected by acute postnatal endometritis because it normalizes most morphological and biochemical indexes of cows by the 10th day, as for immunologic indexes, they are normalized by the 20th day.